Evidence map›Paper›PMID 40830433›Full record

ArticleBMC infectious diseases2025

Epidemiology of tuberculosis and HIV coinfection among inpatients in chengdu, china, 2018-2022.

Xian-Zhen Tang, Yan Ma, Yao Ma, Qing Chen, Li-Ping Zou, Xiao-Yan Fu, Tao Huang, Shen-Jie Tang, Gui-Hui Wu

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. CD4Frontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xian-Zhen Tang *Department of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China.
Yan Ma *Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yao Ma *Department of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China.
Qing ChenDepartment of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China.
Li-Ping ZouDepartment of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China.
Xiao-Yan FuDepartment of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China.
Tao HuangDepartment of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China.
Shen-Jie TangBeijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, China. tangsj1106@vip.sina.com.
Gui-Hui WuDepartment of Tuberculosis, Public Health Clinical Center of Chengdu, 377 Jingming Rd, Chengdu City, 610000, China. wuguihuicd@126.com.

Funding

Science and Technology Department of Sichuan Province Project 2023YFS0220
6 · The paper itself

Abstract

backgroundTuberculosis (TB) and human immunodeficiency virus (HIV) infection are infectious diseases that pose serious threats to human health. TB and HIV can interact to promote the progression of diseases. This study aims to provide basic evidence for the formulation of disease prevention and control strategies.

methodA retrospective study was conducted to analyze the characteristics of demographics and comorbidity, in an attempt to identify factors associated with HIV and TB coinfection among TB inpatients at Public Health Clinical Center of Chengdu, China from January 2018 to December 2022.

resultsAmong 37,587 TB inpatients, HIV-positive and HIV-negative TB cases accounted for 6.1% (2,301) and 93.9% (35,286), respectively.11.9% (4,468) were extrapulmonary tuberculosis (EPTB), of which 6.2%(278) were HIV-positive EPTB. Among TB, the most common types of HIV-positive TB were pulmonary tuberculosis (PTB) (87.9% [2,023]), tuberculous pleurisy (34.4% [791]), and lymph node tuberculosis (33.1% [762]). The proportion of HIV-positive TB decreased from 7.0% in 2018 to 5.1% in 2022 (P < 0.001), showing a downward trend. Factors associated with HIV-positive TB included being 18–59 years of age, male sex, divorced or widowed status, and urban residence. The comorbidity factors associated with HIV-positive TB included hepatitis C infection and syphilis. Those with HIV-positive TB were more likely to be complicated with opportunistic infections, including cryptococcal infection, toxoplasma infection, cytomegalovirus (CMV) infection, and Pneumocystis jirovecii pneumonia (PjP).

conclusionEarly screening for HIV in TB with associated factors, comprehensive management, and control of comorbidities may significantly contribute to achieving the WHO End TB Strategy targets.

Indexed as

CoinfectionHIV InfectionsTuberculosisAdolescentAdultAgedChinaComorbidityFemaleHumansInpatientsMaleMiddle AgedRetrospective StudiesYoung AdultComorbidityEpidemiologyHuman immunodeficiency virus infectionTuberculosis

Identifiers

PMID40830433
PMCPMC12366068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.